Enliven Therapeutics, Inc. (NASDAQ: ELVN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
ELVN QT 90Enliven Therapeutics, Inc. · NASDAQ
61.11 +5.29%
Short Interest History · Twice monthly
Settlement Date Short Interest Avg Daily Volume Shares Float Short Float % Short Ratio Jul-15-26 8.65M 1.31M 45.61M 18.97% 6.60 Jun-30-26 8.53M 1.39M 45.61M 18.69% 6.15 Jun-15-26 5.43M 1.31M 45.61M 11.90% 4.15 May-29-26 5.21M 1.08M 45.61M 11.43% 4.85 May-15-26 5.12M 1.09M 45.61M 11.23% 4.68 Apr-30-26 5.27M 1.12M 45.61M 11.56% 4.69 Apr-15-26 5.37M 1.16M 45.61M 11.78% 4.63 Mar-31-26 6.05M 1.29M 45.61M 13.27% 4.70 Mar-13-26 8.22M 1.05M 45.61M 18.01% 7.85 Feb-27-26 7.98M 1.02M 45.61M 17.49% 7.82 Feb-13-26 8.08M 996.00K 45.61M 17.71% 8.11 Jan-30-26 7.87M 997.86K 45.61M 17.25% 7.89
▼ Show All 82 Periods
